Mode
Text Size
Log in / Sign up

Meta-analysis of perioperative probiotics shows non-significant reduction in postoperative infections for GI surgery patientsProbiotics May Cut Infection Risk After Gut Surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that probiotic efficacy narrowly missed statistical significance in this meta-analysis of GI surgery patients.

This meta-analysis examined the impact of perioperative probiotic use on postoperative infections in patients undergoing gastrointestinal surgery. The review included 755 participants and analyzed outcomes for overall postoperative infections and wound infection. No specific comparator or setting details were reported in the source data.

For overall postoperative infections, the analysis yielded an odds ratio of 0.57 with a 95% CI of 0.32–1.01 and a p-value of 0.057. In the subgroup analysis for multi-strain Lactobacillus and Bifidobacterium, a relative risk of 0.64 was observed with a 95% CI of 0.49–0.83. For wound infection specifically, the odds ratio was 0.61 with a 95% CI of 0.35–1.06 and a p-value of 0.073.

The authors highlight that the overall effect narrowly missed statistical significance. Safety data, adverse events, and discontinuations were not reported. The study limitations include the lack of statistical significance for the primary outcome. Practice relevance is limited to potential inclusion in Enhanced Recovery After Surgery protocols for major gastrointestinal surgery, pending further evidence.

Surgery on the digestive system can save lives, but infections after the operation are a real worry. A new look at the research suggests a simple step may help. Taking specific probiotics before and after gut surgery may lower the chance of infection.

This matters because infections after surgery can slow recovery, raise costs, and increase the risk of serious problems. Many people who have stomach or bowel surgery face this challenge. Current care focuses on antibiotics and sterile technique, but infections still happen. Patients and caregivers often ask what else can be done safely.

For years, probiotics have been linked to better gut health. But the evidence for surgery has been mixed. Some studies showed benefit, while others did not. This made doctors unsure about using them. But here is the twist. The type of probiotic may be the key. A new analysis shows that multi-strain formulas may work better than single strains.

Think of your gut as a busy city. Good bacteria are the helpful workers that keep things running. After surgery, stress and antibiotics can disrupt the balance. Probiotics act like a fresh crew of workers that restore order. Multi-strain formulas are like a diverse team with different skills. They may cover more tasks and protect the gut more effectively.

The new review combined data from eight randomized trials with 755 people. All had gastrointestinal surgery. Researchers looked at how often infections occurred after the operation. They compared people who took probiotics with those who did not. The analysis used standard methods to pool results and check for consistency.

The overall results were promising but not quite decisive. The chance of any postoperative infection was lower with probiotics, but the finding was just shy of statistical significance. Wound infections also trended lower. However, when researchers focused on multi-strain Lactobacillus and Bifidobacterium formulas, the benefit became clear. The risk of infection dropped by about 35 percent.

Here is what that means in real numbers. For every seven patients who took these specific probiotics, one extra infection was prevented. This is called a number needed to treat of seven. It is a strong signal that this approach can help in everyday care.

This does not mean every probiotic product will work the same.

The analysis points to a specific type of formula. Multi-strain blends that include Lactobacillus and Bifidobacterium were the ones that showed a clear benefit. Single strains or different mixes were not as consistent. This suggests that the right recipe matters.

Experts in surgery and recovery are taking note. Enhanced Recovery After Surgery programs already focus on nutrition, mobility, and pain control. Adding a targeted probiotic could fit well within these plans. The goal is to support the body’s natural defenses without adding risk.

For patients, this may mean a simple conversation with the surgical team. Ask whether a multi-strain probiotic could be part of your recovery plan. It is not a replacement for antibiotics or sterile technique. It is an extra tool that may help reduce infections. Always check with your doctor before starting any supplement.

The review has limits. It includes a small number of studies and participants. Not all trials used the same probiotic strains or doses. Some results were close to the line of significance. Larger, more uniform studies are needed to confirm the benefit and refine recommendations.

Looking ahead, researchers plan to test specific probiotic protocols in more detail. Future trials may compare different strains, doses, and timing. If the results hold up, probiotics could become a standard part of care for gut surgery. For now, the evidence supports a careful, targeted approach that may help many patients recover with fewer infections.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundPostoperative infections remain a major cause of morbidity and mortality following gastrointestinal surgery. This meta-analysis aims to evaluate the efficacy of perioperative probiotic use in reducing postoperative infections (POI).MethodsEight randomized controlled trials (RCTs) with 755 participants were included. The effect size was calculated as the Odds Ratio (OR) and Risk Ratio (RR) using a random-effects model.ResultsThe pooled analysis suggested a potential benefit in reducing overall postoperative infections [OR: 0.57 (95% CI: 0.32–1.01); P = 0.057] and wound infection [OR: 0.61 (95% CI: 0.35–1.06); P = 0.073]. While the overall effect narrowly missed statistical significance, subgroup analysis revealed a statistically significant reduction in POI when multi-strain Lactobacillus and Bifidobacterium formulations were used [RR: 0.64 (95% CI: 0.49–0.83)]. The absolute risk reduction (ARR) for this multi-strain subgroup was 13.5%, corresponding to a highly favorable number needed to treat (NNT) of 7.ConclusionThe current evidence regarding the overall efficacy of perioperative probiotics in decreasing postoperative infectious complications narrowly misses statistical significance. However, the targeted use of multi-strain Lactobacillus and Bifidobacterium formulations significantly reduces the risk of infectious complications. These specific regimens offer a clinically meaningful benefit and support its inclusion in Enhanced Recovery After Surgery (ERAS) protocols for patients undergoing major gastrointestinal surgery.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.